A Randomized, Double-blind, Placebo-controlled Trial on the Preventive Effect of Intravaginal Prasterone (DHEA, Intrarosa) on Recurrent Urinary Tract Infections in Women With Genitourinary Syndrome of Menopause
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Prasterone (Primary)
- Indications Urinary tract infections
- Focus Therapeutic Use
Most Recent Events
- 25 Jun 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 23 Mar 2020 Planned initiation date changed from 1 Feb 2020 to 1 May 2020.
- 06 Feb 2020 Planned initiation date changed from 1 Nov 2019 to 1 Feb 2020.